Fluorolintane exhibits high-affinity NMDA antagonism (Ki = 87.92 nM) with even stronger dopamine and norepinephrine transporter blockade, producing stimulant-euphoriant effects at light doses. ED50 for sensorimotor-gating disruption in rats is 13.3 mg/kg i.p. Subjective duration is shorter than diphenidine but more compulsive. Acute side effects include tachycardia, hypertension, nystagmus, and delayed urinary retention. No human pharmacokinetic data exists; rat microsome studies suggest elimination half-life of 4-8 hours with active hydroxylated metabolites.
Fluorolintan molecular structure diagram from the DrugsPRO substance library.
Also known as: 2-fppp, 2-f-dppy
Classification
Chemical: Diarylethylamine
Psychoactive: Dissociative
Psychoactive: Stimulant
Tag: Habit-Forming
Tag: Hallucinogen
Tag: Research-Chemical
Tag: Tentative
Effects
Stimulation
Physical Euphoria
Increased Heart Rate
Sedation
Incoordination
Numbness
Euphoria
Dissociation
Time Distortion
Motor Control Loss
Thought Loop
Confusion
Light Sensitivity
Tactile Suppression
Double Vision
Open Eye Visuals
Visual Disconnection
Disinhibition
Routes of Administration
Oral / Sublingual
Dosage
Threshold: 30 mg
Light: 30-80 mg
Common: 80-150 mg
Strong: 150-250 mg
Heavy: 250 mg
Duration
Onset: 0.33-0.75 h
Comeup: 0.5-1 h
Peak: 1-2 h
Offset: 2-3 h
After Effects: 12 h
Insufflated
Dosage
Threshold: 15 mg
Light: 15-40 mg
Common: 40-90 mg
Strong: 90-150 mg
Heavy: 150 mg
Duration
Onset: 0.08-0.25 h
Comeup: 0.25-0.5 h
Peak: 1-2 h
Offset: 2-3 h
After Effects: 12 h
Rectal
Dosage
Threshold: 20 mg
Light: 20-60 mg
Common: 60-120 mg
Strong: 120-180 mg
Heavy: 180 mg
Duration
Onset: 0.17-0.33 h
Comeup: 0.33-0.67 h
Peak: 1-2 h
Offset: 2-3 h
After Effects: 12 h
Oral
Dosage
Common: 100-150 mg
Heavy: 250 mg
Light: 75-100 mg
Strong: 150-250 mg
Duration
No data available for this section yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Fluorolintane - DrugsPRO substansvejledning
Fluorolintane: Fluorolintane exhibits high-affinity NMDA antagonism (Ki = 87.92 nM) with even stronger dopamine and norepinephrine transporter blockade, producing stimulant-euphoriant effects at light doses. ED50 for sensorimotor-gating disruption in rats is 13.3 mg/kg i.p. Subjective duration is sh
